New Delhi: Covid-19 has become endemic in India, top scientists at the Department of Biotechnology (DBT) monitoring the virus have said, ruling out the risk of any severe fresh outbreak.

Abbott warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 testing demand, new U.S. tariffs, and the government's foreign aid freeze.

ABBOTT warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in Covid-19 testing demand, new US tariffs and the government’s foreign aid freeze.

Abbott Laboratories (ABT) reports robust earnings growth and margin expansion, driven by medical devices, despite headwinds ...

Second-quarter reported sales growth of 7.4 percent; organic sales growth of 6.9 percent or 7.5 percent excluding COVID-19 testing-related sales1 Second-quarter ...

Abbott eyes Q2 growth with strong CGM momentum, cardiac device wins and resilient performance across key segments.

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Nike is scheduled to post fiscal fourth-quarter results after the market closes on Thursday, with investors expecting a ...

Every year, horseshoe crabs are harvested for their blue blood, but alternatives are now coming through that could help ...

From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 pandemic?